Masakazu Takeuchi

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 14

Top Venues

Diabetes therapy : research, treatment and education of diabetes and related disorders

Diabetes, obesity & metabolism

Osaka University (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Osaka University Apr 01 2006 - Mar 31 2010

Japan

PHD

Publications

Yukiko Onishi, Tomonori Oura, Masakazu Takeuchi
Metabolic Abnormalities Following Tirzepatide Monotherapy in Japanese Patients with Type 2 Diabetes: A Phase 3 SURPASS J-mono Post Hoc Analysis. Diabetes therapy : research, treatment and education of diabetes and related disorders 15 (3) (2024)
Kazuya Fujihara, Yasuhiro Matsubayashi, Masaru Kitazawa, Takaaki Sato, Masakazu Takeuchi, Tomonori Oura, Hirohito Sone
Achieving normoglycaemia with tirzepatide: Post hoc exploratory analysis of the SURPASS J-mono and J-combo studies. Diabetes, obesity & metabolism (2024)
Tomoaki Morioka, Masakazu Takeuchi, Akichika Ozeki, Masanori Emoto
A randomized, double-blind trial assessing the efficacy and safety of two doses of dulaglutide in Japanese participants with type 2 diabetes (AWARD-JPN). Diabetes, obesity & metabolism 26 (8) (2024)
Yukiko Onishi, Tomonori Oura, Masakazu Takeuchi
Metabolic Abnormalities Following Tirzepatide Monotherapy in Japanese Patients with Type 2 Diabetes: A Phase 3 SURPASS J-mono Post Hoc Analysis. Diabetes therapy : research, treatment and education of diabetes and related disorders 15 (3) (2024)
Tomoaki Morioka, Masakazu Takeuchi, Akichika Ozeki, Masanori Emoto
A randomized, double-blind trial assessing the efficacy and safety of two doses of dulaglutide in Japanese participants with type 2 diabetes (AWARD-JPN). Diabetes, obesity & metabolism (2024)
Yukiko Onishi, Tomonori Oura, Masakazu Takeuchi
Metabolic Abnormalities Following Tirzepatide Monotherapy in Japanese Patients with Type 2 Diabetes: A Phase 3 SURPASS J-mono Post Hoc Analysis. Diabetes therapy : research, treatment and education of diabetes and related disorders 15 (3) (2024)
Yukiko Onishi, Tomonori Oura, Masakazu Takeuchi
Metabolic Abnormalities Following Tirzepatide Monotherapy in Japanese Patients with Type 2 Diabetes: A Phase 3 SURPASS J-mono Post Hoc Analysis. Diabetes therapy : research, treatment and education of diabetes and related disorders (2024)
Tomoaki Morioka, Masakazu Takeuchi, Akichika Ozeki, Masanori Emoto
A randomized, double-blind trial assessing the efficacy and safety of two doses of dulaglutide in Japanese participants with type 2 diabetes (AWARD-JPN). Diabetes, obesity & metabolism 26 (8) (2024)
Yukiko Onishi, Tomonori Oura, Masakazu Takeuchi
Metabolic Abnormalities Following Tirzepatide Monotherapy in Japanese Patients with Type 2 Diabetes: A Phase 3 SURPASS J-mono Post Hoc Analysis. Diabetes therapy : research, treatment and education of diabetes and related disorders 15 (3) (2024)
Hitoshi Ishii, Tomonori Oura, Masakazu Takeuchi
Treatment Satisfaction and Quality of Life with Tirzepatide Versus Dulaglutide Among Japanese Patients with Type 2 Diabetes: Exploratory Evaluation of the SURPASS J-mono Trial. Diabetes therapy : research, treatment and education of diabetes and related disorders (2023)
Wanxin Han, Lei Wang, Kento Ohbayashi, Masakazu Takeuchi, Libbey O'Farrell, Tamer Coskun, Yermek Rakhat, Daisuke Yabe, Yusaku Iwasaki, Yutaka Seino, Toshihiko Yada
Glucose-dependent insulinotropic polypeptide counteracts diet-induced obesity along with reduced feeding, elevated plasma leptin and activation of leptin-responsive and proopiomelanocortin neurons in the arcuate nucleus. Diabetes, obesity & metabolism (2023)
Daisuke Yabe, Dan Kawamori, Yusuke Seino, Tomonori Oura, Masakazu Takeuchi
Change in pharmacodynamic variables following once-weekly tirzepatide treatment versus dulaglutide in Japanese patients with type 2 diabetes (SURPASS J-mono substudy). Diabetes, obesity & metabolism (2022)
Yukiko Onishi, Hitoshi Ishii, Tomonori Oura, Masakazu Takeuchi
Efficacy and Safety of Once-Weekly Dulaglutide in Type 2 Diabetes Patients Using Insulin: Exploratory Subgroup Analysis by Insulin Regimen. Diabetes therapy : research, treatment and education of diabetes and related disorders 11 (3) (2020)
Hitoshi Ishii, Yukiko Onishi, Tomonori Oura, Masakazu Takeuchi
Once-Weekly Dulaglutide with Insulin Therapy for Type 2 Diabetes: Efficacy and Safety Results from a Phase 4, Randomized, Placebo-Controlled Study. Diabetes therapy : research, treatment and education of diabetes and related disorders 11 (1) (2019)

Masakazu Takeuchi.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Masakazu Takeuchi